C O M M U N I C A T I O N S
of enantiomeric intermediates. Yamamoto and co-workers have
(6) Selected references: (a) Taniguchi, M.; Hino, T. Tetrahedron 1981, 37,
487. (b) Marsden, S. P.; Depew, K. M.; Danishefsky, S. J. J. Am. Chem.
1
demonstrated that BINOL•SnCl
4
behaves as a Lewis acid assisted
Soc. 1994, 116, 11143. (c) Overman, L. E.; Paone, D. V.; Stearns, B. A.
J. Am. Chem. Soc. 1999, 121, 7702. (d) Austin, J. F.; Kim, S. G.; Sinz,
C. J.; Xiao, W. J.; MacMillan, D. W. C. Proc. Natl. Acad. Sci. U.S.A.
Brønsted acid that promotes a number of enantioselective proton-
1
1a-b
ation reactions.
tivities to be observed when employing an excess of SnCl
to BINOL. The observation that at least 1 equiv of SnCl is required
for high conversions, coupled with the fact that use of strong
It is unusual, however, for high enantioselec-
2
004, 101, 5482. (e) Trost, B. M.; Quancard, J. J. Am. Chem. Soc. 2006,
4
relative
128, 6314. (f) Lindel, T.; Br a¨ uchle, L.; Golz, G.; B o¨ hrer, P. Org. Lett.
2
007, 9, 283. (g) Kim, J.; Ashenhurst, J. A.; Movassaghi, M. Science 2009,
4
3
24, 238. (h) Newhouse, T.; Baran, P. S. J. Am. Chem. Soc. 2008, 130,
10886. (i) Espejo, V. R.; Li, X.-B.; Rainier, J. D. J. Am. Chem. Soc. 2010,
132, 8282.
2
4
4
Brønsted acids in the absence of SnCl fails to provide 7d, may
(
7) For the direct arylation of indoles to provide racemic dehydroindolines,
see: (a) Barton, D. H. R.; Bhatnagar, N. Y.; Blazejewski, J. C.; Charpiot,
B.; Fibet, J. P.; Lester, D. J.; Motherwell, W. B.; Papoula, M. T. B.;
Stanforth, S. P. J. Chem. Soc., Perkin Trans. 1 1985, 2657. (b) Eastman,
K.; Baran, P. S. Tetrahedron 2009, 65, 3149.
suggest that this reaction benefits from cooperative Lewis
acid-Brønsted acid activation.
In conclusion, a convergent method to prepare enantioenriched
pyrroloindolines is described. The optimal conditions employ (R)-
4
BINOL as a catalyst in the presence of stoichiometric SnCl and
(
8) For the direct preparation of enantioenriched pyrroloindolines from indoles,
see refs 6d and 6e.
(
9) Angelini, E.; Balsamini, C.; Bartoccini, F.; Lucarini, S.; Piersanti, G. J.
Org. Chem. 2008, 73, 5654.
provide access to functionalized pyrroloindolines in uniformly high
ee’s. The application of this methodology to the total synthesis of
pyrroloindoline natural products and studies aimed at understanding
the mechanism of this new transformation are the focus of ongoing
(
(
10) See Supporting Information.
11) For reports of asymmetric catalysis by BINOL•SnCl , see:(a) Ishihara, K.;
4
Nakamura, S.; Kaneeda, M.; Yamamoto, H. J. Am. Chem. Soc. 1996, 118,
1
2854. (b) Ishihara, K.; Kurihara, H.; Yamamoto, H. J. Am. Chem. Soc.
996, 118, 3049. (c) Yu, S. H.; Ferguson, M. J.; McDonald, R.; Hall, D. G.
1
2
5
research in our laboratory.
J. Am. Chem. Soc. 2005, 127, 12808. (d) Rauniyar, V.; Zhai, H. M.; Hall,
D. G. J. Am. Chem. Soc. 2008, 130, 8481. For a review, see: (e) Yamamoto,
H.; Futatsugi, K. Angew. Chem., Int. Ed. 2005, 44, 1924.
Acknowledgment. We thank Dr. Scott Virgil for insightful
discussions; Drs. Michael Day and Larry Henling for X-ray
crystallographic structural determination; and Prof. Brian Stoltz and
the Caltech Center for Catalysis and Chemical Synthesis for access
to analytical equipment. HRMS and X-ray crystallographic data
were obtained on instruments purchased through awards to the
California Institute of Technology by the NSF CRIF program (CHE-
(
12) The relative stereochemistry of exo-7b was confirmed by single crystal
X-ray diffraction; the relative stereochemistry of exo-7a and the remaining
compounds were assigned by analogy. The absolute stereochemistry has
not been confirmed at this time.
(
13) BINOL catalyzes the addition of allyl and alkynyl boronates to aldehydes. (a)
Wu, T. R.; Chong, J. M. J. Am. Chem. Soc. 2005, 127, 3244. (b) Lou, S.;
Moquist, P. N.; Schaus, S. E. J. Am. Chem. Soc. 2006, 128, 12660. (c)
Wu, T. R.; Chong, J. M. J. Am. Chem. Soc. 2007, 129, 4908. (d) Lou, S.;
Moquist, P. N.; Schaus, S. E. J. Am. Chem. Soc. 2007, 129, 15398. (e)
Lou, S.; Schaus, S. E. J. Am. Chem. Soc. 2008, 130, 6922.
0
639094, CHE-0541745). NMR spectra were obtained on a
(
14) Whereas organotin reagents are known for their toxicity, inorganic tin(IV)
spectrometer funded by the NIH (RR027690). Financial support
from the California Institute of Technology and the Baxter
Foundation is gratefully acknowledged.
compounds are relatively nontoxic: Howe, P.; Watts, P. Tin and Inorganic
4
Tin Compounds. World Health Organization: Switzerland, 2005. SnCl is
available from Sigma-Aldrich for $30/mol, and (R)-BINOL is approximately
$10 000/mol.
(
15) Acrylates 9, 10, and 11 are prepared in one step from the commercially
available materials. See Supporting Information for details.
16) A small screen of BINOL derivatives was also conducted, in which several
3,3′-difunctionalized-(R)-BINOL catalysts were found to provide diminished
rates and selectivities.
Supporting Information Available: Experimental details, charac-
terization data, and NMR spectral charts. This material is available
free of charge via the Internet at http://pubs.acs.org.
(
(
17) Use of 3-methylindole provided the corresponding pyrroloindoline in 18%
yield as a 8:1 exo/endo mixture. The exo diastereomer was formed in 95%
ee.
References
(
18) Das, B. C.; Cosson, J. P.; Lukacs, G.; Potier, P. Tetrahedron Lett. 1974,
15, 4299.
(
1) Anthoni, U.; Christophersen, C.; Nielsen, P. H. Naturally Occurring
Cyclotryptophans and Cyclotryptamines. In Alkaloids: Chemical & Biologi-
cal PerspectiVes; Pelletier, S. W., Ed.; Pergamon: Oxford, 1999; Vol. 13,
pp 163-236.
(19) Massiot, G.; Thepenier, P.; Jacquier, M.-J.; Le Men-Olivier, L.; Delaude,
C. Heterocycles 1989, 29, 1435.
(20) See ref 6a.
(
2) Physostigmine, a reversible cholinesterase inhibitor: Shaw, K. T. Y.; Utsuki,
T.; Rogers, J.; Yu, Q. S.; Sambamurti, K.; Brossi, A.; Ge, Y. W.; Lahiri,
D. K.; Greig, N. H. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 7605.
(21) Crich, D.; Bruncko, M.; Natarajan, S.; Teo, B. K.; Tocher, D. A.
Tetrahedron 1995, 51, 2215.
(22) As determined by chiral stationary phase SFC. See Supporting Information
for details.
(
3) Lansai B, an anti-inflammatory agent: (a) Tuntiwachwuttikul, P.; Taechowisan,
T.; Wanbanjob, A.; Thadaniti, S.; Taylor, W. C. Tetrahedron 2008, 64, 7583.
(23) A reversible, nonselective conjugate addition followed by a moderately
diastereoselective cyclization cannot be ruled out at this time. Diastereo-
merically pure solutions of endo-7d or exo-7d do not equilibrate upon re-
exposure to SnCl (1.2 equiv) and (R)-BINOL (0.2 equiv) in CD Cl .
(
b) Taechowisan, T.; Wanbanjob, A.; Tuntiwachwuttikul, P.; Liu, J. Food
Agric. Immunol. 2009, 20, 67.
(
4) Chaetocin, an HDAC inhibitor: (a) Isham, C. R.; Tibodeau, J. D.; Jin, W.;
Xu, R.; Timm, M. M.; Bible, K. C. Blood 2007, 2579. Leptosins, DNA
topoisomerase inhibitors: (b) Yanagihara, M.; Sasaki-Takahashi, N.;
Sugahara, T.; Yamamoto, S.; Shinomi, M.; Yamashita, I.; Hayashida, M.;
Yamanoha, B.; Numata, A.; Yamori, T.; Andoh, T. Cancer Sci. 2005, 96,
4
2
2
(24) For example, use of HCl (1.2 equiv) or diphenylphosphate (1.2 equiv) failed
to promote the formal [3 + 2] reaction.
(25) As we were preparing to submit this manuscript, similar findings for the
preparation of racemic pyrroloindolines were reported: Lucarini, S.;
Bartoccini, F.; Battistoni, F.; Diamantini, G.; Piersanti, G.; Righi, M.;
Spadoni, G. Org. Lett. 2010, 12, 3844.
8
16.
(
5) Reviews: (a) Crich, D.; Banerjee, A. Acc. Chem. Res. 2007, 40, 151. (b)
Steven, A.; Overman, L. E. Angew. Chem., Int. Ed. 2007, 46, 5488. (c)
Kim, J.; Movassaghi, M. Chem. Soc. ReV. 2009, 38, 3035.
JA107328G
1
4420 J. AM. CHEM. SOC. 9 VOL. 132, NO. 41, 2010